Annapolis Financial Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$81.2K Buy
252
+2
+0.8% +$654 0.02% 127
2024
Q2
$78.1K Hold
250
0.03% 126
2024
Q1
$71.1K Hold
250
0.02% 127
2023
Q4
$72K Sell
250
-20
-7% -$5.45K 0.02% 174
2023
Q3
$72.6K Hold
270
0.02% 163
2023
Q2
$59.9K Hold
270
0.02% 171
2023
Q1
$65.3K Hold
270
0.02% 158
2022
Q4
$70.9K Sell
270
-50
-16% -$13.4K 0.02% 154
2022
Q3
$72K Buy
320
+50
+19% +$12.1K 0.03% 157
2022
Q2
$66K Hold
270
0.02% 161
2022
Q1
$65K Hold
270
0.02% 169
2021
Q4
$61K Buy
270
+20
+8% +$4.22K 0.02% 172
2021
Q3
$53K Hold
250
0.02% 166
2021
Q2
$61K Hold
250
0.02% 150
2021
Q1
$62K Hold
250
0.02% 146
2020
Q4
$57K Buy
+250
New +$57.6K 0.02% 142

Other funds holding AMGN

Annapolis Financial Services's AMGN Position: Q3 2024 in Review

Annapolis Financial Services increased its Amgen (AMGN) stake by 0.8% in Q3 2024, buying an estimated $654 and bringing the position to 252 shares worth $81.2K. The position accounts for 0.02% of the portfolio, ranked #127.

Annapolis Financial Services first reported a position in AMGN in Q4 2020 and has held it in 16 quarters since. 2,823 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • Annapolis Financial Services held 252 shares of Amgen worth $81.2K as of Q3 2024.
  • Annapolis Financial Services bought 2 Amgen shares in Q3 2024, an estimated $654.
  • Amgen made up 0.02% of Annapolis Financial Services's portfolio in Q3 2024, its #127 holding.
  • Annapolis Financial Services first reported a position in Amgen in Q4 2020 and has held it in 16 quarters since.
  • 2,823 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Annapolis Financial Services's 13F filing for Q3 2024, filed 16 Oct 2024.